Moreover, the frequency of administration of a combination of antimalarial drugs and immunosuppressive agents was higher for the SLE patients carrying the BAFF-var allele (8 of 18, 44%) than for those without this allele (35 of 177, 20%) (p = 0.008; OR, 3.3; 95% CI, 1.19–8.83), as shown in Table 4. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.